Objectives The aim of this study is to identify prognostic factors of persistent disease activity and long quiescence in systemic lupus erythematosus (SLE). Methods Patients enrolled in the Hopkins Lupus Cohort from 1987 to 2012, who attended at least three visits per year during 3 consecutive years following baseline and had available information on disease activity were included. Patterns of SLE disease activity over the 3-year period were defined as: persistent long quiescent (pLQ), persistent relapsing-remitting (pRR), persistent chronic active (pCA) and mixed based on Modified SLE Disease Activity Index (M-SLEDAI). Possible predictors of pCA (vs pLQ, pRR and mixed) and pLQ (vs pCA, pRR and mixed) were identified by univariate and multi...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Abstract Background We sought to examine the disease course of High Disease Activity Status (HDAS) p...
Objectives The aim of this study is to identify prognostic factors of persistent disease activity an...
Objectives The aim of this study is to identify prognostic factors of persistent disease activity an...
Objective: To determine the predictors of remission and low disease activity state (LDAS) in patient...
AIM: To assess the prevalence of prolonged remission in Caucasian patients affected with systemi...
AIM: To assess the prevalence of prolonged remission in Caucasian patients affected with systemic ...
OBJECTIVES: To identify predictors of organ damage and specifically the relationship between prolong...
Objective: Several indices have been proposed to assess disease activity in patients with Systemic L...
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
OBJECTIVE: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE: To evaluate the prevalence, duration and effect on damage accrual of the 'Lupus Low Dise...
Background: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Abstract Background We sought to examine the disease course of High Disease Activity Status (HDAS) p...
Objectives The aim of this study is to identify prognostic factors of persistent disease activity an...
Objectives The aim of this study is to identify prognostic factors of persistent disease activity an...
Objective: To determine the predictors of remission and low disease activity state (LDAS) in patient...
AIM: To assess the prevalence of prolonged remission in Caucasian patients affected with systemi...
AIM: To assess the prevalence of prolonged remission in Caucasian patients affected with systemic ...
OBJECTIVES: To identify predictors of organ damage and specifically the relationship between prolong...
Objective: Several indices have been proposed to assess disease activity in patients with Systemic L...
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
OBJECTIVE: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE: To evaluate the prevalence, duration and effect on damage accrual of the 'Lupus Low Dise...
Background: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Abstract Background We sought to examine the disease course of High Disease Activity Status (HDAS) p...